Proteomics

Dataset Information

0

Human liver cell line LO2 LC-MS/MS


ABSTRACT: A hyperlipidaemia model of L02 cells was established using free fatty acids (FFA, oleate and palmitate, 2:1; Sigma-Aldrich, USA) at a final concentration of 1 mM for 24 h. Cells were allowed to attach overnight prior to HTG-medicated serum for 24 h and then exposed to FFA during drug treatment. After treatment, LO2 cells were harvest and stored at -80 ℃, lactylation proteomics was performed by Jingjie PTM BioLabs (Hangzhou, China).

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Li Min  

LAB HEAD: Qingyong He

PROVIDER: PXD045069 | Pride | 2024-01-26

REPOSITORIES: Pride

altmetric image

Publications

Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis.

Yin Xiangjun X   Li Min M   Wang Yongzhi Y   Zhao Guifang G   Yang Tao T   Zhang Yuqing Y   Guo Jianbo J   Meng Tiantian T   Du Ruolin R   Li Honglin H   Wang Zhe Z   Zhang Jian J   He Qingyong Q  

Clinical epigenetics 20231102 1


<h4>Background</h4>Huazhuo Tiaozhi granule (HTG) is a herbal medicine formula widely used in clinical practice for hypolipidaemic effects. However, the molecular mechanisms underlying dyslipidaemia treatment have not been well elucidated.<h4>Results</h4>A significant reduction in the levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) was observed in the serum of patients with dyslipidaemia after HTG treatment, without disruption in the levels of aspartate transamina  ...[more]

Similar Datasets

2019-10-05 | E-MTAB-7318 | biostudies-arrayexpress
2021-10-13 | E-MTAB-11084 | biostudies-arrayexpress
2021-10-29 | E-MTAB-11117 | biostudies-arrayexpress
2015-05-20 | E-GEOD-68460 | biostudies-arrayexpress
2017-10-13 | GSE90095 | GEO
2023-08-29 | PXD040514 | Pride
2016-08-08 | E-GEOD-77212 | biostudies-arrayexpress
2015-03-10 | E-GEOD-66655 | biostudies-arrayexpress
2018-08-08 | PXD007906 | Pride
2023-07-21 | PXD040481 | Pride